+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030- Product Image
Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030- Product Image
Sale

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4857894
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Microbiome Market size was estimated at USD 1.58 billion in 2023, USD 1.96 billion in 2024, and is expected to grow at a CAGR of 23.90% to reach USD 7.11 billion by 2030.

The human microbiome is the collective genomes of the microorganisms that reside on and inside the human body. These include bacteria, archaea, viruses, and eukaryotic microbes. The human body hosts trillions of these microbial cells, which can influence bodily functions and health. It assists in the digestion of food, protection against pathogens, and the development of the immune system.

Meanwhile, the rise in chronic disease prevalence and a growing need for research linking the microbiome to various health conditions further stokes demand for microbiome-based diagnostics and therapeutics. The growing need for a microbiome in nutrition propels the demand for a human microbiome to support and influence overall wellness and immune function.

However, the regulatory hurdles associated with approving live biotherapeutic products and complexities in comprehending and manipulating the microbiome present a significant challenge for the key players. Companies are continuously focusing on research and development (R&D) activities and cost-effective and accessible sequencing technologies to optimize their business growth. Moreover, the advancements in developing novel human microbiome therapeutics and rising investments present a significant opportunity for the key companies operating in the global space. Emerging technologies such as artificial intelligence (AI) and advanced machine learning (ML) are integrated with microbiome research to understand complex microbial interactions better and develop novel therapeutic solutions.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in human microbiome driven by the research and commercialization of advanced microbiome, with numerous companies actively engaged in developing microbiome-based therapies and diagnostics. The human microbiome landscape in this region is steadily growing, focusing on research aimed at understanding the impact of the microbiome on human health and disease. On the other hand, European countries exhibit strong government support for microbiome research with numerous initiatives and research consortia in place. The regulatory framework in Europe is evolving to support the safe and ethical use of microbiome data and products.

The Middle East and Africa region represents a growing market for human microbiome products, primarily driven by an increasing burden of lifestyle diseases and growing healthcare expenditure. At the same time, the human microbiome landscape in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness of the importance of microbial balance to overall health, rising healthcare expenditures, and advancements in microbial genomics. Research and development in probiotics, prebiotics, and symbiotics are growing in this region, particularly in addressing regional health issues such as gastrointestinal disorders and chronic diseases.

Market Trends by Segment

  • Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
  • Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Clinical Microbiomics Announces Merger with CosmosID

Clinical Microbiomics A/S, microbiome bioinformatics, and systems biology company merged with CosmosID Inc., an American CRO specializing in microbiome analysis compliant with CLIA and GxP standards. The merger creates an unprecedented microbiome service provider poised with a worldwide network of cutting-edge multi-omics laboratories, fortified by robust bioinformatics, the application of artificial intelligence, and the expertise in integrative systems biology adhering to GxP guidelines.

Nestlé Partners APC Microbiome on Health and Wellbeing Products

Nestlé embarked on a groundbreaking partnership with APC Microbiome Ireland, a research institution funded by Science Foundation Ireland, to delve deeper into the intricacies of the human microbiome. This partnership is poised to revolutionize Nestlé's health and wellness product range by incorporating advanced microbiome science into new product development. By leveraging APC Microbiome Ireland's cutting-edge research capabilities, Nestlé plans to leverage the complex interplay between nutrition and gut health, enhancing their offerings and fostering better health outcomes for consumers.

UW Medicine Launches a New Center to Study Microbiomes

UW Medicine inaugurated the Microbial Interactions & Microbiome Center, which stands at the forefront of investigating the complex ecosystems of microorganisms residing in varied habitats, including human niches such as the gastrointestinal tract, oral cavity, and skin. Central to the center's mission is to expand the understanding of the intricate relationships within these microbial communities comprised of bacteria, fungi, and myriad other minuscule organisms.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., Azitra, BiomeSense, Inc., BiomX Ltd., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Illumina, Inc., Intralytix, Inc., Invivo Healthcare, Locus Biosciences, Inc., Merck KGaA, Metabiomics Corporation, Osel Inc., Rebiotix Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc., and Yakult Honsha Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Human Microbiome Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
5.1.2. Restraints
5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
5.1.4. Challenges
5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
5.2. Market Segmentation Analysis
5.2.1. Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
5.2.2. Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
5.9.1. Intellectual Property Landscape
6. Human Microbiome Market, by Disease
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. Human Microbiome Market, by Product
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. Human Microbiome Market, by Therapeutic Area
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health
10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. Americas Human Microbiome Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Human Microbiome Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Human Microbiome Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Clinical Microbiomics Announces Merger with CosmosID
14.3.2. Nestlé Partners APC Microbiome on Health and Wellbeing Products
14.3.3. UW Medicine Launches a New Center to Study Microbiomes
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 94. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 95. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 100. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 101. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 104. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 105. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 110. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 111. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 148. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 149. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 154. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 155. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 158. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 159. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 160. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 161. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 164. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 165. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 175. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 178. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 179. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 184. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 185. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 215. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 225. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 235. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 238. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 239. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 244. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 245. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 255. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 269. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 270. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 271. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 276. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 277. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 280. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 281. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 286. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 287. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 290. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 291. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 296. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 297. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 306. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 307. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 310. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 311. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 312. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 313. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 316. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 317. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 326. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 327. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 340. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 341. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 342. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 343. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 346. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 347. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 350. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 351. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 352. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 353. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 356. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 357. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 360. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 361. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 362. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TEC

Companies Mentioned

  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • Azitra
  • BiomeSense, Inc.
  • BiomX Ltd.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Illumina, Inc.
  • Intralytix, Inc.
  • Invivo Healthcare
  • Locus Biosciences, Inc.
  • Merck KGaA
  • Metabiomics Corporation
  • Osel Inc.
  • Rebiotix Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc.
  • Yakult Honsha Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.11 Billion
Compound Annual Growth Rate23.9%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT), and Region - Forecast to 2029 - Product Image

Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT), and Region - Forecast to 2029

  • Report
  • 183 Pages
  • Global
From
Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] - Product Image

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]

  • Report
  • 209 Pages
  • Global
From
Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030 - Product Image

Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Human Microbiome Modulators Market Size & Market Share Data, Latest Trend Analysis and Future Growth Intelligence Report - Forecast by Product, by Application, by Distribution Channel, Analysis and Outlook from 2023 to 2030 - Product Image

Human Microbiome Modulators Market Size & Market Share Data, Latest Trend Analysis and Future Growth Intelligence Report - Forecast by Product, by Application, by Distribution Channel, Analysis and Outlook from 2023 to 2030

  • Report
  • 162 Pages
  • Global
From
Global Human Microbiome Market Report and Forecast 2023-2031 - Product Image

Global Human Microbiome Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From

About the Human Microbiome Market

The Human Microbiome market is a subset of the biotechnology industry that focuses on the study of the human microbiome. The human microbiome is the collection of microorganisms that live in and on the human body, and it plays an important role in human health. The Human Microbiome market is focused on understanding the role of the microbiome in health and disease, and developing products and services to improve human health. This includes the development of diagnostics, therapeutics, and probiotics. The Human Microbiome market is driven by advances in technology, such as next-generation sequencing, which has enabled researchers to better understand the microbiome and its role in health and disease. Additionally, the increasing prevalence of chronic diseases, such as obesity and diabetes, has increased the demand for microbiome-based products and services. Companies in the Human Microbiome market include uBiome, Second Genome, and Seres Therapeutics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.